UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT.
Publication
, Conference
Faasld, HLTM; Rockey, DC; Suzuki, A; Merz, M; Herrmann, R
Published in: HEPATOLOGY
2020
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
731A / 732A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Faasld, H. L. T. M., Rockey, D. C., Suzuki, A., Merz, M., & Herrmann, R. (2020). UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT. In HEPATOLOGY (Vol. 72, pp. 731A-732A).
Faasld, Hans L Tillmann Md, Don C. Rockey, Ayako Suzuki, Michael Merz, and Richard Herrmann. “UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT.” In HEPATOLOGY, 72:731A-732A, 2020.
Faasld HLTM, Rockey DC, Suzuki A, Merz M, Herrmann R. UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT. In: HEPATOLOGY. 2020. p. 731A-732A.
Faasld, Hans L. Tillmann Md, et al. “UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT.” HEPATOLOGY, vol. 72, 2020, pp. 731A-732A.
Faasld HLTM, Rockey DC, Suzuki A, Merz M, Herrmann R. UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT. HEPATOLOGY. 2020. p. 731A-732A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
731A / 732A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics